Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGunawan, Stephen Nathaniel.
dc.description.abstractSince its rediscovery in 1973, Photodynamic Therapy (PDT) has emerged to be one of the novel cancer treatment modalities. In its very essence, it exploits light-activated drugs or better known as photosensitisers, and laser light to induce selective cytotoxicity. The effect of photosensitiser concentration, blood oxygenation level, and sufficient light on the site play a major role in PDT’s clinical success.[1] A non-invasive therapy monitoring method is simplified by the development of Diffuse Optical Spectroscopy (DOS), where several important chromophores such as oxygenated haemoglobin (HbO2), deoxygenated haemoglobin (Hb), and photosensitiser concentration can be monitored constantly to provide a preliminary overview on the therapy progress[2] for clinicians to chart the subsequent courses of action.en_US
dc.format.extent63 p.en_US
dc.rightsNanyang Technological University
dc.subjectDRNTU::Science::Medicine::Optical instruments
dc.titleWhite light diffuse optical spectroscopy for therapy monitoringen_US
dc.typeFinal Year Project (FYP)en_US
dc.contributor.supervisorLee Kijoonen_US
dc.contributor.schoolSchool of Chemical and Biomedical Engineeringen_US
dc.description.degreeBachelor of Engineering (Chemical and Biomolecular Engineering)en_US
item.fulltextWith Fulltext-
Appears in Collections:SCBE Student Reports (FYP/IA/PA/PI)
Files in This Item:
File Description SizeFormat 
  Restricted Access
1.5 MBAdobe PDFView/Open

Page view(s)

Updated on Dec 8, 2021


Updated on Dec 8, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.